Literature DB >> 17140564

Ribavirin uptake by cultured human choriocarcinoma (BeWo) cells and Xenopus laevis oocytes expressing recombinant plasma membrane human nucleoside transporters.

Takashi Yamamoto1, Kenichi Kuniki, Yoh Takekuma, Takeshi Hirano, Ken Iseki, Mitsuru Sugawara.   

Abstract

We investigated the mechanism of the transport of ribavirin (1-beta-D-ribofuranosyl-1,2,4-trizole-3-carboxamide) into placental epithelial cells using human choriocarcinoma (BeWo) cells and Xenopus oocytes expressing human nucleoside transporters. In BeWo cells, when a relatively low concentration (123 nM) of ribavirin was used, both Na(+)-dependent uptake and -independent uptake of ribavirin were observed. On the other hand, when a higher concentration (100 microM) of ribavirin was used, Na(+)-independent uptake was observed, but there was only a slight Na(+)-dependent uptake. In Xenopus oocytes, influxes of ribavirin mediated by hCNT2 (concentrative nucleoside transporter 2), hCNT3 (concentrative nucleoside transporter 3), hENT1 (equilibrative nucleoside transporter 1) and hENT2 (equilibrative nucleoside transporter 2) were saturable, and apparent K(m) values were 18.0 microM, 14.2 microM, 3.46 mM and 3.71 mM, respectively. These data indicate that hCNT2 and hCNT3 have higher affinity for ribavirin than do hENT1 and hENT2. Moreover, analysis by RT-PCR showed that BeWo cells express mRNA of hCNT3, hENT1 and hENT2. These results suggest that ribavirin is taken up by BeWo cells via both the high-affinity Na(+)-dependent transporter hCNT3 and the low-affinity Na(+)-independent transporters hENT1 and hENT2.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17140564     DOI: 10.1016/j.ejphar.2006.10.062

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  19 in total

Review 1.  The role of transporters in the toxicity of nucleoside and nucleotide analogs.

Authors:  Christopher A Koczor; Rebecca A Torres; William Lewis
Journal:  Expert Opin Drug Metab Toxicol       Date:  2012-04-18       Impact factor: 4.481

Review 2.  The application and mechanism of action of ribavirin in therapy of hepatitis C.

Authors:  Emmanuel Thomas; Marc G Ghany; T Jake Liang
Journal:  Antivir Chem Chemother       Date:  2012-09-25

3.  Population pharmacokinetic modeling of plasma and intracellular ribavirin concentrations in patients with chronic hepatitis C virus infection.

Authors:  Liviawati S Wu; Joseph E Rower; James R Burton; Peter L Anderson; Kyle P Hammond; Fafa Baouchi-Mokrane; Gregory T Everson; Thomas J Urban; David Z D'Argenio; Jennifer J Kiser
Journal:  Antimicrob Agents Chemother       Date:  2015-02-02       Impact factor: 5.191

Review 4.  Ribavirin as an anti-cancer therapy: acute myeloid leukemia and beyond?

Authors:  Katherine L B Borden; Biljana Culjkovic-Kraljacic
Journal:  Leuk Lymphoma       Date:  2010-10

Review 5.  A pharmacological profile of ribavirin and monitoring of its plasma concentration in chronic hepatitis C infection.

Authors:  Girish S Naik; Manoj G Tyagi
Journal:  J Clin Exp Hepatol       Date:  2012-04-12

6.  Striking species difference in the contribution of concentrative nucleoside transporter 2 to nucleoside uptake between mouse and rat hepatocytes.

Authors:  Tomomi Furihata; Yukina Fukuchi; Minami Iikura; Misato Hashizume; Atsushi Miyajima; Miki Nagai; Kan Chiba
Journal:  Antimicrob Agents Chemother       Date:  2010-04-26       Impact factor: 5.191

7.  Multiple Drug Transporters Contribute to the Placental Transfer of Emtricitabine.

Authors:  Qingquan Zeng; Mengru Bai; Cui Li; Shuanghui Lu; Zhiyuan Ma; Yunchun Zhao; Hui Zhou; Huidi Jiang; Dongli Sun; Caihong Zheng
Journal:  Antimicrob Agents Chemother       Date:  2019-07-25       Impact factor: 5.191

8.  ENT1, a ribavirin transporter, plays a pivotal role in antiviral efficacy of ribavirin in a hepatitis C virus replication cell system.

Authors:  Minami Iikura; Tomomi Furihata; Misa Mizuguchi; Miki Nagai; Masanori Ikeda; Nobuyuki Kato; Akihito Tsubota; Kan Chiba
Journal:  Antimicrob Agents Chemother       Date:  2012-01-09       Impact factor: 5.191

9.  Host-based ribavirin resistance influences hepatitis C virus replication and treatment response.

Authors:  Kristie D Ibarra; Mamta K Jain; Julie K Pfeiffer
Journal:  J Virol       Date:  2011-05-04       Impact factor: 5.103

10.  The role of nucleoside transporters in the erythrocyte disposition and oral absorption of ribavirin in the wild-type and equilibrative nucleoside transporter 1-/- mice.

Authors:  Christopher J Endres; Aaron M Moss; Rajgopal Govindarajan; Doo-Sup Choi; Jashvant D Unadkat
Journal:  J Pharmacol Exp Ther       Date:  2009-07-14       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.